Lunit International Limited

Lunit International Limited is a healthcare AI software company specializing in cancer detection and precision oncology. Founded in 2013 with headquarters in Seoul and offices in Boston, the company develops clinically validated, FDA-cleared AI solutions that enhance cancer screening and treatment optimization. Lunit's modular ecosystem integrates imaging analysis, digital pathology, and biomarker intelligence across radiology, pathology, and oncology workflows. The platform serves over 10,000 customer sites across 65+ countries, with deployments focused on early detection in breast cancer, lung cancer, and personalized treatment selection through AI-powered biomarker analysis and immunohistochemistry quantification.